Zero Point Five Therapeutics
Pre-clinicalZero Point Five Therapeutics develops small molecule inhibitors targeting protein-protein interactions for cancer treatment.
Founded
2020
Focus
OncologySmall Molecules
About
Zero Point Five Therapeutics develops small molecule inhibitors targeting protein-protein interactions for cancer treatment.
Funding History
1Total raised: $4M
Seed$4MMPM CapitalMay 15, 2022
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile